Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial
155 Pancreatic polypeptide deficient patients, as a result of pancreatic resection or chronic pancreatitis, exhibit reversed hepatic insulin resistance upon pancreatic polypeptide infusion
Medications like semaglutide (Wegovy) and tirzepatide (Zepbound) are generally superior to diet and exercise alone in terms of the total amount of weight loss achieved
The starting dosage is 0.8 milligrams (mg), increased to 2.5 mg after at least 30 days, and then to 5.5 mg after another 30 days
It is not FDA-approved and is not available by prescription in Hollywood, Miami, West Palm Beach, or anywhere in Florida outside of approved clinical trials
These reductions appeared partially independent of weight loss, suggesting potential direct anti-inflammatory effects